3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione(CAS: 1189516-65-1)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires proper hazard communication. In Europe, it is regulated under REACH, and in the United States, it may be subject to FDA and EPA guidelines. Specific regulatory requirements include safety data sheets (SDS) and proper handling and disposal procedures.

Several alternatives can be used in the synthesis of this compound. Common substitutes include related piperidinyl compounds with different substituents, as well as other 2-aryl-1-piperidinyl derivatives. These alternatives can provide similar functional groups and structural features for varying applications.

The market for this compound is growing as it finds applications in pharmaceuticals, particularly in the development of anti-inflammatory and anti-neoplastic drugs. Research trends indicate increasing interest in its synthesis and potential therapeutic uses, driven by its unique chemical structure and biological activity.

Waste containing this compound should be collected and disposed of in accordance with local regulations. Preferred methods include incineration with proper pollution control measures or professional waste disposal services. Safety precautions include handling in a fume hood, wearing appropriate personal protective equipment, and ensuring proper labeling and documentation of waste disposal procedures.